4 results match your criteria: "ICON Centre[Affiliation]"
J Neurol
December 2024
IUSS Cognitive Neuroscience (ICoN) Centre, Scuola Universitaria Superiore IUSS Di Pavia, Piazza Della Vittoria 15, 27100, Pavia, Italy.
Background: More than 100 million children in the world have at least one type of disability. Among disabled children, approximately 25% of chronic disabilities are of neurological origin. Cerebral Palsy is the leading cause of chronic disability in children, making them not only physically and mentally handicapped but also socially aloof.
View Article and Find Full Text PDFTher Innov Regul Sci
September 2024
Lyell Immunopharma, Seattle, WA, USA.
Chimeric antigen receptor (CAR) T-cell therapy is a human gene therapy product where T cells from a patient are genetically modified to enable them to recognize desired target antigen(s) more effectively. In recent years, promising antitumor activity has been seen with autologous CAR T cells. Since 2017, six CAR T-cell therapies for the treatment of hematological malignancies have been approved by the Food and Drug Administration (FDA).
View Article and Find Full Text PDFBrain Inform
July 2022
Indian Institute of Science, CV Raman Rd, Bengaluru, 560012, Karnataka, India.
Autism spectrum is a brain development condition that impairs an individual's capacity to communicate socially and manifests through strict routines and obsessive-compulsive behavior. Applied behavior analysis (ABA) is the gold-standard treatment for autism spectrum disorder (ASD). However, as the number of ASD cases increases, there is a substantial shortage of licensed ABA practitioners, limiting the timely formulation, revision, and implementation of treatment plans and goals.
View Article and Find Full Text PDF